• Consensus Rating: Buy
  • Consensus Price Target: $119.13
  • Forecasted Upside: 36.85%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$87.05
▼ -0.73 (-0.83%)

This chart shows the closing price for CVS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CVS Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

Analyst Price Target is $119.13
▲ +36.85% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $119.13, with a high forecast of $130.00 and a low forecast of $101.00. The average price target represents a 36.85% upside from the last price of $87.05.

This chart shows the closing price for CVS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 polled investment analysts is to buy stock in CVS Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/8/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/6/2021
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/4/2022
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/5/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/3/2022
  • 0 strong buy ratings
  • 18 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/1/2022
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/31/2022
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/13/2023Morgan StanleyBoost TargetOverweight$119.00 ➝ $120.00Low
1/3/2023Wells Fargo & CompanyLower TargetEqual Weight$106.00 ➝ $101.00Low
11/23/2022Morgan StanleyLower TargetOverweight$124.00 ➝ $119.00Low
11/21/2022Credit Suisse GroupBoost TargetOutperform$117.00 ➝ $125.00Low
11/8/2022Wells Fargo & CompanyLower TargetEqual Weight$111.00 ➝ $106.00Low
11/7/2022Royal Bank of CanadaLower TargetOutperform$119.00 ➝ $115.00Low
11/6/2022Raymond JamesLower Target$120.00 ➝ $115.00Low
11/3/2022JPMorgan Chase & Co.Lower TargetOverweight$130.00 ➝ $125.00Low
11/3/2022The Goldman Sachs GroupLower TargetBuy$128.00 ➝ $113.00Low
10/20/2022Bank of AmericaLower TargetBuy$122.00 ➝ $118.00Low
10/11/2022Morgan StanleyLower TargetOverweight$127.00 ➝ $124.00Low
9/7/2022Evercore ISIBoost TargetOutperform$120.00 ➝ $125.00Low
8/17/2022Tigress FinancialBoost Target$125.00 ➝ $130.00Low
8/15/2022MizuhoBoost TargetBuy$115.00 ➝ $120.00Low
8/8/2022Credit Suisse GroupBoost TargetOutperform$113.00 ➝ $117.00Low
8/4/2022UBS GroupBoost TargetBuy$118.00 ➝ $127.00Low
8/4/2022Deutsche Bank AktiengesellschaftBoost Target$113.00 ➝ $120.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$120.00Medium
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$122.00 ➝ $112.00Medium
5/5/2022Deutsche Bank AktiengesellschaftBoost Target$110.00 ➝ $113.00High
4/7/2022Tigress FinancialBoost Target$122.00 ➝ $125.00Low
3/29/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$110.00High
2/17/2022Deutsche Bank AktiengesellschaftBoost Target$107.00 ➝ $110.00Medium
2/11/2022Raymond JamesDowngradeStrong-Buy ➝ Outperform$115.00 ➝ $120.00High
2/10/2022BMO Capital MarketsBoost Target$108.00 ➝ $120.00Medium
1/12/2022Robert W. BairdBoost Target$107.00 ➝ $110.00Low
1/11/2022Sanford C. BernsteinBoost Target$111.00 ➝ $116.00Low
1/10/2022Edward JonesUpgradeHold ➝ BuyMedium
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$118.00 ➝ $124.00Low
12/23/2021Tigress FinancialBoost TargetBuy$108.00 ➝ $122.00Low
12/20/2021MizuhoBoost TargetBuy$110.00 ➝ $115.00Low
12/14/2021Robert W. BairdReiterated RatingHoldLow
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$121.00Low
12/13/2021Morgan StanleyBoost TargetOverweight ➝ Overweight$115.00 ➝ $125.00Low
12/13/2021Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$98.00 ➝ $107.00Low
12/13/2021Robert W. BairdBoost TargetNeutral ➝ Neutral$100.00 ➝ $107.00Low
12/10/2021Truist FinancialBoost TargetBuy ➝ Buy$112.00 ➝ $118.00Low
12/10/2021CowenBoost TargetOutperform ➝ Outperform$103.00 ➝ $114.00Low
12/10/2021Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$107.00 ➝ $119.00Medium
12/10/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$107.00 ➝ $120.00Medium
12/10/2021MizuhoBoost TargetBuy ➝ Buy$105.00 ➝ $110.00Medium
12/6/2021Morgan StanleyBoost TargetOverweight$114.00 ➝ $115.00Medium
12/1/2021Seaport Res PtnReiterated RatingBuyMedium
11/10/2021MizuhoBoost TargetBuy$98.00 ➝ $105.00Low
11/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$101.00 ➝ $107.00Medium
11/5/2021Credit Suisse GroupBoost TargetOutperform$100.00 ➝ $107.00Low
11/5/2021JPMorgan Chase & Co.Boost TargetBuy ➝ Overweight$107.00 ➝ $115.00Low
11/4/2021Truist FinancialBoost TargetBuy$94.00 ➝ $112.00Medium
11/4/2021Royal Bank of CanadaBoost TargetOutperform$97.00 ➝ $107.00Medium
11/4/2021Raymond JamesBoost TargetStrong-Buy$95.00 ➝ $115.00Medium
11/4/2021CitigroupBoost TargetBuy$98.00 ➝ $111.00Medium
11/4/2021BarclaysBoost TargetOverweight$100.00 ➝ $110.00Medium
10/21/2021MizuhoReiterated RatingBuyMedium
8/31/2021Morgan StanleyBoost TargetTop Pick ➝ Overweight$99.00 ➝ $114.00High
8/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$95.00 ➝ $101.00High
7/23/2021Tigress FinancialReiterated RatingBuy$108.00Low
6/22/2021Deutsche Bank AktiengesellschaftLower TargetBuy$99.00 ➝ $95.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00N/A
5/19/2021BMO Capital MarketsBoost TargetPositive ➝ Market Perform$90.00 ➝ $96.00High
5/19/2021BarclaysBoost TargetOverweight$92.00 ➝ $100.00High
5/19/2021Wolfe ResearchBoost TargetPositive ➝ Outperform$82.00 ➝ $93.00High
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00Medium
5/12/2021MizuhoBoost TargetPositive ➝ Buy$82.00 ➝ $98.00Low
5/6/2021Credit Suisse GroupBoost TargetOutperform$91.00 ➝ $100.00Low
5/6/2021BMO Capital MarketsBoost TargetMarket Perform$82.00 ➝ $90.00Low
5/5/2021CitigroupBoost Target$83.00 ➝ $98.00Medium
5/5/2021Jefferies Financial GroupBoost TargetBuy$90.00 ➝ $95.00Medium
5/5/2021Raymond JamesBoost TargetStrong-Buy$90.00 ➝ $95.00High
5/5/2021Royal Bank of CanadaBoost TargetOutperform$80.00 ➝ $91.00High
4/14/2021Truist FinancialBoost TargetBuy$80.00 ➝ $88.00Low
4/14/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $92.00Medium
3/23/2021GuggenheimReiterated RatingBuy ➝ NeutralMedium
3/17/2021GuggenheimDowngradeBuy ➝ NeutralLow
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$90.00Low
12/14/2020SVB LeerinkBoost TargetMarket Perform$73.00 ➝ $80.00High
11/11/2020Piper SandlerBoost TargetOverweight$72.00 ➝ $76.00Low
11/9/2020Cantor FitzgeraldReiterated RatingOverweightHigh
11/9/2020Deutsche Bank AktiengesellschaftLower TargetBuy$104.00 ➝ $101.00High
9/17/2020Piper SandlerInitiated CoverageOverweight$72.00 ➝ $72.00Medium
8/7/2020Credit Suisse GroupBoost TargetOutperform$75.00 ➝ $90.00Medium
8/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$109.00 ➝ $104.00Low
8/6/2020SVB LeerinkBoost TargetMarket Perform$72.00 ➝ $73.00Low
7/9/2020Royal Bank of CanadaReiterated RatingBuyLow
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$72.00Low
5/14/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$75.00Low
5/8/2020Credit Suisse GroupReiterated RatingHoldLow
5/7/2020Robert W. BairdBoost TargetNeutral$62.00 ➝ $66.00Low
5/7/2020UBS GroupLower TargetBuy$85.00 ➝ $79.00Low
5/7/2020CitigroupLower TargetBuy$86.00 ➝ $75.00Low
5/7/2020Morgan StanleyBoost TargetOverweight$71.00 ➝ $77.00Low
5/6/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
5/6/2020OppenheimerReiterated RatingHoldHigh
5/4/2020JPMorgan Chase & Co.Lower TargetOverweight$97.00 ➝ $94.00Low
4/24/2020Tigress FinancialReiterated RatingBuyMedium
4/13/2020Morgan StanleyBoost TargetOverweight$70.00 ➝ $71.00Low
4/13/2020SunTrust BanksLower TargetBuy$90.00 ➝ $80.00Medium
4/12/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
3/27/2020Morgan StanleyLower TargetOverweight$88.00 ➝ $70.00Medium
3/27/2020Robert W. BairdLower TargetNeutral$73.00 ➝ $62.00Medium
3/25/2020Royal Bank of CanadaLower Target$85.00 ➝ $81.00Medium
3/19/2020Credit Suisse GroupReiterated RatingHold$75.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$97.00 ➝ $109.00Low
2/14/2020CitigroupBoost TargetBuy$83.00 ➝ $86.00Medium
2/13/2020Robert W. BairdBoost TargetNeutral$70.00 ➝ $73.00Medium
2/13/2020UBS GroupBoost TargetBuy$78.00 ➝ $85.00Medium
2/13/2020Cantor FitzgeraldBoost TargetOverweight$85.00 ➝ $90.00Medium
2/12/2020OppenheimerInitiated CoverageHoldMedium
2/12/2020CfraBoost TargetStrong-Buy$85.00 ➝ $86.00Medium
12/19/2019JPMorgan Chase & Co.Boost TargetOverweight$88.00 ➝ $97.00Low
12/4/2019Raymond JamesReiterated RatingStrong-Buy$80.00 ➝ $90.00Low
11/8/2019MizuhoBoost TargetBuy$71.00 ➝ $82.00Low
11/7/2019UBS GroupReiterated RatingBuy$78.00 ➝ $78.00Low
11/7/2019Raymond JamesBoost TargetStrong-Buy$75.00 ➝ $80.00Low
11/7/2019SunTrust BanksBoost TargetBuy$85.00Low
11/7/2019CitigroupBoost TargetBuy$72.00 ➝ $83.00Low
10/21/2019CowenSet TargetBuy$76.00Low
9/27/2019Royal Bank of CanadaInitiated CoverageOutperform$85.00Low
9/26/2019Morgan StanleyBoost TargetOverweight$74.00 ➝ $77.00Medium
9/12/2019Bank of AmericaBoost TargetBuy$72.00 ➝ $75.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$91.00Medium
8/27/2019CowenReiterated RatingOutperform$69.00 ➝ $76.00Medium
8/11/2019Morgan StanleyReiterated RatingBuy$74.00Low
8/8/2019CitigroupBoost TargetBuy$68.00 ➝ $72.00Medium
8/7/2019Evercore ISISet TargetBuy$63.00Low
6/5/2019MizuhoSet TargetBuy$71.00Medium
6/5/2019Standpoint ResearchUpgradeHold ➝ BuyHigh
5/3/2019BMO Capital MarketsSet TargetHold$63.00Low
5/2/2019CitigroupSet TargetBuy$74.00Low
5/2/2019UBS GroupLower TargetSell ➝ Sell$74.00 ➝ $67.00Low
5/1/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/29/2019Morgan StanleyLower TargetOverweight ➝ Overweight$92.00 ➝ $74.00Low
4/29/2019Credit Suisse GroupDowngradeOutperform ➝ Neutral$73.00 ➝ $61.00Medium
4/21/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/18/2019Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$90.00 ➝ $75.00Low
4/18/2019GuggenheimInitiated CoverageBuy ➝ Buy$90.00 ➝ $75.00Low
4/15/2019CIBCReiterated RatingOutperform ➝ Market PerformLow
4/15/2019OppenheimerDowngradeOutperform ➝ Market PerformLow
4/11/2019BarclaysSet TargetBuy$73.00High
4/10/2019BMO Capital MarketsInitiated CoverageOutperform$58.00Medium
4/10/2019SunTrust BanksLower Target$85.00 ➝ $65.00Low
4/10/2019Bank of AmericaReiterated RatingBuy$82.00 ➝ $74.00Low
3/12/2019Sanford C. BernsteinInitiated CoverageOutperform ➝ Outperform$76.00High
3/6/2019CitigroupLower TargetBuy ➝ Buy$94.00 ➝ $68.00Medium
2/25/2019ArgusLower TargetBuy ➝ Positive$100.00 ➝ $80.00Low
2/22/2019Morgan StanleySet TargetBuy$92.00Low
2/21/2019SunTrust BanksLower TargetBuy$85.00Medium
2/21/2019UBS GroupLower TargetBuy ➝ Buy$75.00 ➝ $74.00High
2/21/2019Loop CapitalLower TargetIn-Line ➝ Hold$68.00High
2/21/2019JPMorgan Chase & Co.Reiterated RatingOverweight$91.00High
2/21/2019Cantor FitzgeraldReiterated RatingOverweight$80.00High
2/20/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$104.00 ➝ $68.00High
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$75.00Low
1/3/2019Cantor FitzgeraldReiterated RatingBuy$96.00Low
1/3/2019Bank of AmericaReiterated RatingBuy$92.00Low
12/18/2018BarclaysInitiated CoverageOverweight ➝ Overweight$91.00Medium
12/11/2018SVB LeerinkInitiated CoverageOutperformMedium
12/2/2018Cantor FitzgeraldInitiated CoverageOverweight$96.00 ➝ $77.84Low
11/29/2018The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$87.00Low
11/28/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$89.00Low
11/28/2018Loop CapitalSet TargetHold$80.00High
11/27/2018Wells Fargo & CompanyBoost TargetOutperform$98.00 ➝ $104.00Medium
11/26/2018Cantor FitzgeraldInitiated CoverageOverweight$96.00High
11/13/2018ArgusBoost TargetBuy$100.00Low
11/9/2018Loop CapitalSet TargetHold$70.00 ➝ $80.00N/A
11/8/2018SVB LeerinkBoost TargetOutperform ➝ Positive$85.00 ➝ $95.00Medium
11/7/2018Morgan StanleySet TargetBuy$80.00 ➝ $100.00Low
11/7/2018Royal Bank of CanadaSet TargetBuy$100.00Medium
10/26/2018Tigress FinancialReiterated RatingBuyLow
10/25/2018Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
10/23/2018Royal Bank of CanadaSet TargetBuy$99.00Low
9/18/2018Royal Bank of CanadaBoost TargetOutperform$101.00Medium
9/17/2018Bank of AmericaBoost TargetBuy$86.00 ➝ $90.00Medium
8/9/2018SVB LeerinkSet TargetOutperform$85.00 ➝ $80.00Low
8/8/2018Royal Bank of CanadaReiterated RatingPositive ➝ Buy$90.00Low
7/9/2018CitigroupReiterated RatingNeutral ➝ Buy$81.00Low
7/3/2018Morgan StanleyLower TargetOverweight ➝ Overweight$88.00 ➝ $80.00Low
6/30/2018MizuhoReiterated RatingBuyLow
6/29/2018Royal Bank of CanadaLower TargetOutperform$84.00Medium
6/13/2018MizuhoSet TargetBuy$95.00High
5/7/2018Loop CapitalSet TargetHold$68.00Medium
4/11/2018Bank of AmericaLower TargetBuy ➝ Buy$91.00 ➝ $88.00Low
4/10/2018SVB LeerinkSet TargetBuy$85.00Low
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$91.00Low
2/13/2018CitigroupSet TargetNeutral ➝ Neutral$80.00 ➝ $77.00Low
2/9/2018SVB LeerinkSet TargetOutperform ➝ Buy$90.00 ➝ $85.00Low
2/9/2018Robert W. BairdLower TargetNeutral ➝ Neutral$85.00 ➝ $80.00Low
2/9/2018Needham & Company LLCSet TargetStrong-Buy ➝ Buy$100.00 ➝ $98.00Medium
2/8/2018Royal Bank of CanadaSet TargetBuy$89.00Medium
(Data available from 1/31/2018 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 33 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
7/4/2022
  • 9 very positive mentions
  • 33 positive mentions
  • 7 negative mentions
  • 2 very negative mentions
8/3/2022
  • 23 very positive mentions
  • 56 positive mentions
  • 12 negative mentions
  • 10 very negative mentions
9/2/2022
  • 32 very positive mentions
  • 50 positive mentions
  • 7 negative mentions
  • 8 very negative mentions
10/2/2022
  • 26 very positive mentions
  • 49 positive mentions
  • 11 negative mentions
  • 5 very negative mentions
11/1/2022
  • 24 very positive mentions
  • 71 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
12/1/2022
  • 12 very positive mentions
  • 34 positive mentions
  • 6 negative mentions
  • 6 very negative mentions
12/31/2022
  • 26 very positive mentions
  • 50 positive mentions
  • 11 negative mentions
  • 8 very negative mentions
1/30/2023

Current Sentiment

  • 26 very positive mentions
  • 50 positive mentions
  • 11 negative mentions
  • 8 very negative mentions

Recent Stories by Sentiment

CVS Health logo
CVS Health Corp. engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate/Other. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long-Term Care segment includes the sale of prescription drugs and an assortment of health and wellness products, and general merchandise. The Health Care Benefits segment provides traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, Medicare Part D prescription drug plan, Medicaid health care management services, and health information technology products and services. The Corporate/Other segment is involved in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Read More

Today's Range

Now: $87.05
Low: $86.99
High: $88.39

50 Day Range

MA: $94.78
Low: $85.75
High: $103.79

52 Week Range

Now: $87.05
Low: $84.82
High: $111.25

Volume

8,014,582 shs

Average Volume

9,713,802 shs

Market Capitalization

$114.38 billion

P/E Ratio

37.04

Dividend Yield

2.76%

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Bank of America Co., BMO Capital Markets, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Tigress Financial, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CVS.

What is the current price target for CVS Health?

16 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $119.13, suggesting a possible upside of 36.8%. Tigress Financial has the highest price target set, predicting CVS will reach $130.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $101.00 for CVS Health in the next year.
View the latest price targets for CVS.

What is the current consensus analyst rating for CVS Health?

CVS Health currently has 3 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CVS will outperform the market and that investors should add to their positions of CVS Health.
View the latest ratings for CVS.

What other companies compete with CVS Health?

How do I contact CVS Health's investor relations team?

CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected] The official website for CVS Health is www.cvshealth.com. Learn More about contacing CVS Health investor relations.